A detailed history of Alpha Paradigm Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Alpha Paradigm Partners, LLC holds 13,008 shares of DXCM stock, worth $1.04 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
13,008
Previous 3,137 314.66%
Holding current value
$1.04 Million
Previous $253,000 482.21%
% of portfolio
0.62%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $838,837 - $1.21 Million
9,871 Added 314.66%
13,008 $1.47 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $239,509 - $295,442
3,137 New
3,137 $253,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Alpha Paradigm Partners, LLC Portfolio

Follow Alpha Paradigm Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.